Results 121 to 130 of about 23,244 (239)

HIF2a regulates ccRCC tumorigenesis through activation of cell cycle regulators [PDF]

open access: yes, 2019
Clear cell renal cell carcinoma (ccRCC) is the most frequent type of kidney cancer, with 50% 5-year survival. Genetically, ccRCCs are characterised by inactivation of VHL which is lost in 90% of cases.

core   +2 more sources

RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 9, September 2026.
RNA‐binding proteins (RBPs) regulate RNA stability, localization, translation, and splicing through intrinsic binding domains and interactions with diverse cellular partners. Their competitive and cooperative networks shape disease‐related RNA programs, especially in cancer.
Ling Li, Xiuli Yan, Qing Ji, Hui Zhang
wiley   +1 more source

USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination

open access: yesCancer Biology & Therapy
Ubiquitin-specific protease 7 (USP7) involves in various human cancers due to its capacity for binding and stabilizing specific target proteins through deubiquitylation, but its roles in clear cell renal cell carcinoma (ccRCC) development remains unknown.
Hongsheng Li   +5 more
doaj   +1 more source

Heat Shock Proteins in Cancer: Mechanisms and Therapeutic Targeting

open access: yesMedComm, Volume 7, Issue 9, September 2026.
This review illustrates heat shock proteins (HSPs) as central regulators of cancer metabolic reprogramming. By stabilizing key metabolic enzymes and coordinating glycolysis, oxidative phosphorylation, redox homeostasis, and stress adaptation, HSPs support tumor growth, metastasis, and therapeutic resistance. Targeting HSP networks may therefore provide
Sheng Ma   +5 more
wiley   +1 more source

SAM of ccRCC tumors against the rest of them.

open access: yes, 2020
ccRCC = Clear cell renal carcinoma.
Guillermo de Velasco (3457934)   +13 more
core   +1 more source

Targeting m6A Modifications Regulating Ferroptosis Offers Novel Therapy in Diseases

open access: yesCell Proliferation, Volume 59, Issue 9, September 2026.
m6A RNA modification regulates ferroptosis by balancing iron metabolism, lipid peroxidation, and antioxidant defenses. Dysregulated m6A signaling disrupts pro‐ and anti‐ferroptotic factors, leading to excess ROS, Fe3+ accumulation, and lipid peroxidation–driven cell death. Targeting m6A‐mediated ferroptotic regulation represents a promising therapeutic
Lida Du   +7 more
wiley   +1 more source

Mean levels of differentially expressed proteins among ccRCC patients (n = 58), healthy controls (n = 64), pre- and post-operatives ccRCC samples (n = 20).

open access: yes, 2014
Mean levels of differentially expressed proteins among ccRCC patients (n = 58), healthy controls (n = 64), pre- and post-operatives ccRCC samples (n = 20).
Yan Gao (93649)   +8 more
core   +1 more source

Immunohistochemical staining for KCa3.1 in ccRCC and oncocytoma.

open access: yes, 2015
Immunohistochemical staining for KCa3.1 in ccRCC (A) and oncocytoma (B) shows strong staining of tumor vessels (long arrows) in both tumor subtypes.
Ralf Köhler (34264)   +8 more
core   +1 more source

Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma

open access: yesBMC Urology
Background Currently, no useful serum markers exist for clear cell renal cell carcinoma (ccRCC), making early detection challenging as diagnosis relies solely on imaging tests. Radiation exposure is also a concern due to multiple required CT examinations
Shotaro Nakanishi   +5 more
doaj   +1 more source

Immunofluorescent staining for CD8 and KCa3.1 in ccRCC and oncocytoma.

open access: yes, 2015
Immunofluorescence of CD8 (red) and KCa3.1 (green) in ccRCC (A) and oncocytoma (B). Large arrows indicate T cells positive for CD8 and KCa3.1. Small arrows indicate T cells positive for CD8 but KCa3.1-negative.
Ralf Köhler (34264)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy